GlaxoSmithKline PLC Re Directorate (0001V)
October 22 2014 - 6:12AM
UK Regulatory
TIDMGSK
RNS Number : 0001V
GlaxoSmithKline PLC
22 October 2014
Change to Director's Details - Dr Moncef Slaoui
GlaxoSmithKline plc (the "Company") today confirms that Dr
Moncef Slaoui, an Executive Director, is appointed Chairman,
Vaccines, with immediate effect.
This appointment will ensure more focused management of the
Company's Vaccines business in advance of the completion of the
proposed 3 part transaction with Novartis announced earlier this
year. Dr Slaoui will continue to provide scientific and technical
counsel on pharmaceutical R&D activities to the CEO and
Board.
Dr Slaoui was previously Chairman, Global R&D and
Vaccines.
V A Whyte
Company Secretary
22 October 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAFEWFFEFLSESS
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024